Clinical Trial Update: Study Evaluating Etanercept for the Treatment of Refractory Heel Enthesitis in Spondylarthropathy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating etanercept for refractory heel enthesitis in spondylarthropathy has completed and results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enthesitis
• Spondyloarthropathies

Drugs mentioned

• Etanercept (Enbrel) (Etanercept)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Spondylarthropathies, Enthesitis | Phase 4 | Status: COMPLETED | Results posted: 2009-11-10